Blue Water Ventures International Inc

Healthcare US BWVI

0.0007USD
0.00(0%)

Last update at 2026-06-23T20:00:00Z

Day Range

0.00030.0003

LowHigh

52 Week Range

0.00010.01

LowHigh

Fundamentals

Previous Close 0.0007
Market Cap0.14M
Volume50000
P/E Ratio-
Dividend Yield-%
Revenue TTM0.00000M
Revenue Per Share TTM-
Gross Profit TTM 0.00000M
Diluted EPS TTM-

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Income before tax	-16.97984M	-1.41459M	-0.11361M	-0.53453M	-1.10854M
Minority interest	-	-	-	-	-
Net income	-16.97984M	-1.41459M	-0.11362M	-0.52943M	-1.06801M
Selling general administrative	-	-	-	-	-
Selling and marketing expenses	-	-	-	-	-
Gross profit	-0.00483M	-	0.08M	0.10M	0.00252M
Reconciled depreciation	-	-	-	-	-
Ebit	-11.24887M	-1.63679M	-0.11361M	-0.49888M	-0.81962M
Ebitda	-11.24404M	-1.40023M	-0.08193M	-0.46558M	-0.79298M
Depreciation and amortization	0.00483M	0.24M	0.03M	0.03M	0.03M
Non operating income net other	-	-	-	-	-
Operating income	-11.35498M	-1.40023M	-0.13510M	-0.49888M	-0.81962M
Other operating expenses	16.98M	1.40M	0.22M	0.60M	0.82M
Interest expense	0.00161M	0.01M	-	0.04M	0.29M
Tax provision	-	-	-	-	-
Interest income	-	-	-	-	-
Net interest income	-	-	-	-	-
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	-0.22848M	-0.23656M	0.00001M	-0.00510M	-0.04053M
Total revenue	-	-	0.08M	0.10M	0.00252M
Total operating expenses	11.35M	1.40M	0.19M	0.57M	0.80M
Cost of revenue	0.00483M	-	-	-	-
Total other income expense net	0.10M	-0.01436M	0.02M	-0.03565M	-0.28892M
Discontinued operations	-	-	-	-	-
Net income from continuing ops	-	-	-	-	-
Net income applicable to common shares	-	-	-	-	-
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Total assets	2.28M	0.33M	1.18M	1.23M	1.29M
Intangible assets	-	-	-	-	-
Earning assets	-	-	-	-	-
Other current assets	0.10M	-	0.03M	0.03M	-
Total liab	2.42M	0.26M	1.21M	1.16M	1.47M
Total stockholder equity	-0.13510M	0.06M	-1.02360M	-0.91997M	-1.17089M
Deferred long term liab	-	-	-	-	-
Other current liab	2.17M	-	-	-	-
Common stock	0.26M	-	0.07M	0.07M	0.06M
Capital stock	-	-	-	-	-
Retained earnings	-18.39863M	-1.47549M	-10.33095M	-10.21733M	-9.68849M
Other liab	-	-	-	-	-
Good will	-	-	-	-	-
Other assets	0.00000M	-	-	-	-
Cash	1.99M	0.33M	0.00840M	-	0.00078M
Cash and equivalents	-	-	-	-	-
Total current liabilities	2.42M	0.26M	0.11M	0.05M	0.30M
Current deferred revenue	-	-	-	-	-
Net debt	-1.94325M	-0.07732M	1.13M	1.11M	1.42M
Short term debt	0.05M	0.25M	0.03M	0.00123M	0.25M
Short long term debt	-	-	-	-	-
Short long term debt total	0.05M	0.25M	1.13M	1.11M	1.42M
Other stockholder equity	18.26M	1.54M	9.24M	9.23M	8.46M
Property plant equipment	-	-	-	-	-
Total current assets	2.09M	0.33M	0.05M	0.04M	0.27M
Long term investments	-	-	-	-	-
Net tangible assets	-	-	-	-	-
Short term investments	-	-	-	-	-
Net receivables	0.00016M	-	0.00900M	0.01000M	0.27M
Long term debt	-	-	-	-	-
Inventory	-	-	-	-	-
Accounts payable	0.20M	0.01M	0.08M	0.05M	0.05M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-0.25673M	-	-	-	-
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	-	-	-
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-	-	-
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	-	-	0.04M	0.04M	0.04M
Deferred long term asset charges	-	-	-	-	-
Non current assets total	0.19M	-	1.13M	1.19M	1.02M
Capital lease obligations	-	-	-	-	-
Long term debt total	-	-	-	-	-

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Investments	-	-	-	-	-
Change to liabilities	-	-	-	-	-
Total cashflows from investing activities	0.55M	-	-	-0.03553M	-0.00663M
Net borrowings	-	-	-	-	-
Total cash from financing activities	4.58M	1.20M	0.04M	0.40M	0.39M
Change to operating activities	-	-	-	-	-
Net income	-16.97984M	-1.41459M	-0.11362M	-0.52943M	-1.06801M
Change in cash	1.67M	0.32M	0.00840M	-0.00078M	-0.04322M
Begin period cash flow	0.33M	0.00840M	-	0.00078M	0.04M
End period cash flow	1.99M	0.33M	0.00840M	-	0.00078M
Total cash from operating activities	-3.46141M	-0.86971M	-0.03446M	-0.36843M	-0.43148M
Issuance of capital stock	-	-	-	-	-
Depreciation	-	-	0.03M	0.03M	0.03M
Other cashflows from investing activities	0.55M	-	-	-	-
Dividends paid	-	-	-	-	-
Change to inventory	-	-	-	-	-
Change to account receivables	-	0.00900M	0.00100M	-0.01000M	-
Sale purchase of stock	-	-	-	-	-
Other cashflows from financing activities	0.55M	-0.16064M	0.00550M	-0.16100M	0.35M
Change to netincome	-	-	-	-	-
Capital expenditures	0.00000M	0.00000M	0.00000M	0.04M	0.00663M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	-	-	-
Change in working capital	0.19M	0.01M	0.03M	-0.03560M	-0.04500M
Stock based compensation	-	-	-	-	-
Other non cash items	13.33M	0.53M	0.02M	0.16M	0.75M
Free cash flow	-3.46141M	-0.86971M	-0.03446M	-0.40396M	-0.43811M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
BWVI Blue Water Ventures International Inc	- -%	0.0007	-	-	0.67	1.76	3.55	43.65
ZTS Zoetis Inc	1.46 1.89%	78.30	40.18	30.96	10.67	17.60	11.27	26.18
MKKGY Merck KGaA ADR	0.83 2.69%	31.72	21.25	14.93	3.10	2.14	3.60	12.98
MKGAF MERCK Kommanditgesellschaft auf Aktien	- -%	155.71	21.73	14.95	3.16	2.15	3.56	12.82
GALDY GALDERMA GROUP AG	1.58 3.64%	45.00	74.21	41.67	8.64	5.55	9.15	42.22

Reports Covered

View All

Profile

Blue Water Ventures International, Inc., through its subsidiary, Psycheceutical Inc., focuses on developing pharmaceutical products and technologies for mental health treatments. The company was incorporated in 2006 and is based in Fort Lauderdale, Florida.

Blue Water Ventures International Inc

515 E. Las Olas Blvd, Fort Lauderdale, FL, United States, 33301

954-868-7366
https://www.psycheceutical.com

Key Executives

Name	Title	Year Born
Mr. W. Keith Webb	Founder, CEO, Pres & Director	NA
Mr. Alan Parks	Chief Financial Officer	NA
Mr. Dan Porter	VP of Operations	NA
Mr. Andy Farber	Corp. Counsel	NA
Mr. John S. Arnone	Director of Bus. Devel.	1958
Mr. James Sinclair MA	Chief Archeologist	NA
Dr. Neilank K. Jha M.D.	CEO & Executive Chairman	NA
Mr. Chadwick Harman	President, COO & Director	NA
Mr. Michael Hlavsa	CFO, Secretary, Treasurer & Director	1954
Dr. Anish Tuteja	Chief Science Officer	NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.